Immediate Impact
1 from Science/Nature 30 standout
Citing Papers
Efficacy and Safety of Upadacitinib in Patients With Moderate to Severe Atopic Dermatitis
2022 Standout
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials
2021 Standout
Works of Toru Ando being referenced
Cellular and molecular mechanisms of IL-5 synthesis in atopic diseases: A study with allergen-specific human helper T cells
1997
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Toru Ando | 94 | 40 | 6 | 47 | 13 | 138 | |
| Mary Hewitt Loveless | 95 | 39 | 20 | 41 | 16 | 240 | |
| V. Liabeuf | 215 | 78 | 51 | 79 | 18 | 238 | |
| Stavroula Giavi | 188 | 69 | 32 | 42 | 13 | 227 | |
| C Domínguez‐Noche | 147 | 77 | 2 | 28 | 19 | 225 | |
| Eva Wollmann | 111 | 32 | 3 | 75 | 11 | 154 | |
| Chiara Tontini | 108 | 32 | 8 | 53 | 23 | 168 | |
| Ans F.M. Lebens | 150 | 59 | 24 | 29 | 8 | 193 | |
| Mueller | 32 | 48 | 13 | 17 | 13 | 177 | |
| Eloína González Mancebo | 153 | 88 | 16 | 57 | 9 | 192 | |
| Inna Tulaeva | 112 | 43 | 3 | 62 | 9 | 156 |
All Works
Loading papers...